美銀證券:平安好醫生(1833.HK)是在線醫療服務行業的領軍者 首予“買入”評級 目標價118港元
美銀證券發表報吿表示,首予平安好醫生(1833.HK)“買入”評級及目標價118港元。美銀證券認為,平安好醫生是在線醫療服務行業的領軍者,其優勢定位可順應醫療保健行業的發展。在需求端,公司全面的“醫療+健康”管理服務和龐大的服務提供商網絡可以帶動更多的用户在平台上消費;在供給端,公司是與保險和企業渠道合作的行業先驅。
美銀證券預期平安好醫生將把握以下幾方面機遇:1)商業健康保險市場快速增長,且公司在保險領域具有競爭優勢,因其可以跟母公司平安集團全方位地深入合作;2)員工醫療福利。平安好醫生可為員工提供全面的醫療保健服務,該行預計公司可通過滲透平安集團的海量客户池,以及增加員工覆蓋率和服務項目以提高人均收入。
美銀證券還預期,公司於2020至2023年度收入年複合增長率將達31%,由2020年度的69億元人民幣上升至2023年度的155億元人民幣;同時料公司將加快其策略性投資步伐,而今明兩年仍會錄顯著non-GAAP淨虧損,直至2023年才有望收窄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.